Scheme Information
Kotak Healthcare Reg IDCW-R
as of 07 Jun 2026, 13:23 PM
SIP Calculator
Invested Amount
₹6,00,000
Est. Return
₹5,61,695
Total Value
₹11,61,695
Scheme Ratings
rated by Value Research
Scheme Riskometer
Your principal will be at Very High Risk
Investment Returns
Absolute Returns
CAGR
Company Holdings
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 14.04% |
| J.B. Chemicals & Pharmaceuticals Ltd | Healthcare | E | 6.63% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 6.31% |
| Divi's Laboratories Ltd | Healthcare | E | 5.90% |
| Fortis Healthcare Ltd | Healthcare | E | 4.84% |
| Acutaas Chemicals Ltd | Basic Materials | E | 4.60% |
| Cipla Ltd | Healthcare | E | 4.22% |
| Park Medi World Ltd | Healthcare | E | 3.79% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | E | 3.56% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 3.08% |
| Lupin Ltd | Healthcare | E | 3.02% |
| Sai Life Sciences Ltd | Healthcare | E | 3.02% |
| Mankind Pharma Ltd | Healthcare | E | 2.72% |
| Aurobindo Pharma Ltd | Healthcare | E | 2.64% |
| Jubilant Pharmova Ltd | Healthcare | E | 2.52% |
| Anthem Biosciences Ltd | Healthcare | E | 2.45% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 2.43% |
| Ajanta Pharma Ltd | Healthcare | E | 2.39% |
| Alkem Laboratories Ltd | Healthcare | E | 2.07% |
| Rubicon Research Ltd | Healthcare | E | 1.96% |
| Corona Remedies Ltd | Healthcare | E | 1.91% |
| Marksans Pharma Ltd | Healthcare | E | 1.86% |
| Gland Pharma Ltd | Healthcare | E | 1.76% |
| Emcure Pharmaceuticals Ltd | Healthcare | E | 1.69% |
| Yatharth Hospital and Trauma Care Services Ltd | Healthcare | E | 1.49% |
| Orchid Pharma Ltd | Healthcare | E | 1.26% |
| Zydus Lifesciences Ltd | Healthcare | E | 1.26% |
| Dr. Lal PathLabs Ltd | Healthcare | E | 1.21% |
| Innova Captab Ltd | Healthcare | E | 1.17% |
| Laxmi Dental Ltd | Healthcare | E | 1.14% |
| Rainbow Childrens Medicare Ltd | Healthcare | E | 1.09% |
| Metropolis Healthcare Ltd | Healthcare | E | 0.76% |
| Medi Assist Healthcare Services Ltd | Healthcare | E | 0.23% |
| Triparty Repo | - | CR | 1.41% |
| Net Current Assets/(Liabilities) | - | C | 0.44% |
| Dr Reddy's Laboratories Ltd | - | E | - |
Sector Holding Analysis
Equity / Debt / Cash Split
Equity
99.03%
Cash
0.97%
Equity sector allocation
Basic Materials
4.6%
Healthcare
94.42%
Others
0.98%
Fund House Contact Details
Asset Management Company
Funds in this Category
Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
31.98%
63.78%
3Y Returns
+63.78%
Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
31.98%
63.78%
3Y Returns
+48.34%
DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
31.98%
63.78%
3Y Returns
+45.98%
About Kotak Healthcare Reg IDCW-R
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Abhishek Bisen
Risk Profile
Very High Risk
Expense Ratio
2.45%
Fund Size
₹496 Cr
FAQ's
What is the expense ratio of Kotak Healthcare Reg IDCW-R?
What is the AUM (Assets Under Management) of Kotak Healthcare Reg IDCW-R?
What are the top stock holdings of Kotak Healthcare Reg IDCW-R?
The Kotak Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 14.04% |
| J.B. Chemicals & Pharmaceuticals Ltd | 6.63% |
| Max Healthcare Institute Ltd Ordinary Shares | 6.31% |
| Divi's Laboratories Ltd | 5.90% |
| Fortis Healthcare Ltd | 4.84% |
| Acutaas Chemicals Ltd | 4.60% |
| Cipla Ltd | 4.22% |
| Park Medi World Ltd | 3.79% |
| Krishna Institute of Medical Sciences Ltd | 3.56% |
| Apollo Hospitals Enterprise Ltd | 3.08% |
| Lupin Ltd | 3.02% |
| Sai Life Sciences Ltd | 3.02% |
| Mankind Pharma Ltd | 2.72% |
| Aurobindo Pharma Ltd | 2.64% |
| Jubilant Pharmova Ltd | 2.52% |
| Anthem Biosciences Ltd | 2.45% |
| Glenmark Pharmaceuticals Ltd | 2.43% |
| Ajanta Pharma Ltd | 2.39% |
| Alkem Laboratories Ltd | 2.07% |
| Rubicon Research Ltd | 1.96% |
| Corona Remedies Ltd | 1.91% |
| Marksans Pharma Ltd | 1.86% |
| Gland Pharma Ltd | 1.76% |
| Emcure Pharmaceuticals Ltd | 1.69% |
| Yatharth Hospital and Trauma Care Services Ltd | 1.49% |
| Orchid Pharma Ltd | 1.26% |
| Zydus Lifesciences Ltd | 1.26% |
| Dr. Lal PathLabs Ltd | 1.21% |
| Innova Captab Ltd | 1.17% |
| Laxmi Dental Ltd | 1.14% |
| Rainbow Childrens Medicare Ltd | 1.09% |
| Metropolis Healthcare Ltd | 0.76% |
| Medi Assist Healthcare Services Ltd | 0.23% |
| Triparty Repo | 1.41% |
| Net Current Assets/(Liabilities) | 0.44% |
| Dr Reddy's Laboratories Ltd | - |
In which sectors has Kotak Healthcare Reg IDCW-R invested in?
The Kotak Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 4.60% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 94.42% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
What is the risk level of Kotak Healthcare Reg IDCW-R?
Who are the fund managers of Kotak Healthcare Reg IDCW-R?
Is there a minimum SIP amount to invest in Kotak Healthcare Reg IDCW-R?
Can I invest in Kotak Healthcare Reg IDCW-R both in SIP and lump sum?
How to invest in Kotak Healthcare Reg IDCW-R?
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Kotak Healthcare Reg IDCW-R:
- On HDFC SKY open your demat account if you don't have one.
- Check the performance of Kotak Healthcare Reg IDCW-R.
- Choose between SIP or Lumpsum and start your mutual fund investment journey on HDFC Sky.
Is there any exit load charges of Kotak Healthcare Reg IDCW-R?
The exit load of Kotak Healthcare Reg IDCW-R is as follows:
Exit load of 0.5%, if redeemed within 1 year
.What is the process to redeem my investment in HDFC SKY?
The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy